Archive for 2018

Goldman Sachs Sees 100% Upside In This Biopharma Company

Courtesy of Benzinga.

Goldman Sachs Sees 100% Upside In This Biopharma Company

Revance Therapeutics Inc (NASDAQ: RVNC) has dropped 9 percent since the start of the year, but it’s begun a path to redemption through a new, respected advocate.

The Rating

Goldman Sachs analysts Dana Flanders and Christopher Staral initiated coverage on Revance with a Buy rating and a $60 price target.

The Thesis

Revance’s injectable DaxibotulinumtoxinA will soon penetrate and rise in a $3 billion global neuromodulator market expected to post 11-percent compound annual growth through 2023.

Goldman Sachs foresees long-term opportunity in the treatment of glabellar lines, cervical dystonia and plantar fasciitis — expectations supported by physician surveys indicating a potential premium to Botox pricing and few challenges from Allergan plc Ordinary Shares (NYSE: AGN)’s cosmetic portfolio.

The analysts forecast peak sales north of $1.1 billion, which may secure Revance looks from outside parties.

“Given the attractiveness of the global neuromodulator market […] and growth potential from label expansion opportunities for Daxi, we also see high likelihood of M&A interest in RVNC over time,” Flanders and Staral wrote in a note.

Risks to their thesis include slow commercial uptake, competition and regulatory roadblocks.

Price Action

Shares spiked 5.4 percent on the coverage initiation. At time of publication, Revance’s stock traded up 1.9 percent off Monday’s open at $31.90.

Related Links:

Botox Competition Spurs Argus To Downgrade Allergan

The Companies That Led 2017′s Biotech Rally

Latest Ratings for RVNC

Date Firm Action From To
Mar 2018 Goldman Sachs Initiates Coverage On Buy
Jan 2018 Guggenheim Downgrades Buy Neutral
Dec 2017 Guggenheim Initiates Coverage On Buy

View More Analyst Ratings for RVNC

View the Latest Analyst Ratings

Posted-In: Christopher Staral Dana Flanders DaxibotulinumtoxinAAnalyst Color Price Target Initiation Top Stories Analyst Ratings Best of Benzinga

Imperial Capital: Alta Mesa Resources Will ‘Grow Into A Much More Attractive Valuation’

Courtesy of Benzinga.

Imperial Capital: Alta Mesa Resources Will 'Grow Into A Much More Attractive Valuation'

Alta Mesa Holdings LP (NASDAQ: AMR) began trading Feb. 9 as part of a combination of Silver Run Acquisition Corporation II, Alta Mesa Holdings LP and Kingfisher Midstream LLC. The combined oil and natural gas entity was renamed Alta Mesa Resources and boasts upstream assets of around 130,000 net acres, mostly in Oklahoma, according to Imperial Capital. 

The Analyst

Imperial Capital’s Irene Haas initiated coverage of Alta Mesa Resources’ stock with an Outperform rating and $10 price target.

The Thesis

In addition to owning 130,000 net acres of upstream assets, the company’s Kingfisher Midstream business owns more than 400 miles of pipelines and its natural gas processing capacity is around 350MMcf/d, Haas said in a Monday note. (See the analyst’s track record here.)

Alta Mesa has also drilled more than 247 horizontal wells and conducted 12 down spacing pilots, the analyst said. 

“We believe AMR has the right acreage, the midstream support and the financial strength to realize a multiyear growth ramp,” Haas said. 

Imperial Capital projects that it will take time for the stock’s valuation to grow from its “mispriced” valuation, since it is a new equity without an established track record. The firm’s $10 price target is based on a proven reserves valuation of $5 per share, a probable reserve valuation of $5 per share, midstream assets valuation of $2 per share and a projected net debt of $2 per share.

Price Action

Alta Mesa shares were up 0.23 percent at $7.49 just before the close of Monday’s trading session. 

Related Links:

The Market In 5 Minutes: AXA Buys XL Group, Biotech Preview, Small Banks

Benzinga Pro’s 5 Stocks To Watch Today

Posted-In: energy energy stocks imperial capital Irene HaasAnalyst Color Price Target Initiation Analyst Ratings Best of Benzinga

A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of Economic Data

Courtesy of Benzinga.

A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of Economic Data

Pre-open movers

U.S. stock futures traded mostly lower in early pre-market trade. US Services Purchasing Managers’ Index for February is schedule for release at 9:45 a.m. ET, while the ISM non-manufacturing index for February will be released at 10:00 a.m. ET. Federal Reserve Vice Chairman Randal Quarles is set to speak in Washington, DC at 1:15 p.m. ET.

Futures for the Dow Jones Industrial Average fell 58 points to 24,477.00, while the Standard & Poor’s 500 index futures fell 5.95 points to 2,684.00. Futures for the Nasdaq 100 index rose 6 points to 6,810.75.

Oil prices traded higher as Brent crude futures rose 0.03 percent to trade at $64.39 per barrel, while US WTI crude futures gained 0.21 percent to trade at $61.38 a barrel.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.44 percent, STOXX Europe 600 Index surging 0.56 percent and German DAX 30 index gaining 0.57 percent. The UK’s FTSE index was trading higher by 0.20 percent, while French CAC 40 Index rose 0.28 percent.

In Asian markets, Japan’s Nikkei Stock Average fell 0.66 percent, Hong Kong’s Hang Seng Index declined 2.28 percent, China’s Shanghai Composite Index rose 0.07 percent and India’s BSE Sensex slipped 0.40 percent.

Broker Recommendation

Analysts at Morgan Stanley upgraded Groupon Inc (NASDAQ: GRPN) from Underweight to Equal-Weight.

Groupon shares rose 1.17 percent to $4.32 in pre-market trading.

Breaking news

  • AXA announced plans to acquire XL Group Ltd. (NYSE: XL) for $57.60 per share in cash.
  • Nuverra Environmental Solutions, Inc. (NYSE: NES) reported the departure of its Chairman and CEO, Mark. D. Johnsrud. The company named Charles K. Thompson as Interim CEO.
  • Harte Hanks Inc (NYSE: HHS) agreed to sell its 3Q Digital business for $5 million.
  • Corindus Vascular Robotics Inc (NASDAQ: CVRS) disclosed that it has received the FDA clearance for the first automated robotic movement in technIQ Series for CorPath GRX platform.

Posted-In: A Peek Into The Markets Morgan StanleyNews Eurozone Commodities Global Pre-Market Outlook Markets

42 Biggest Movers From Friday

Courtesy of Benzinga.


  • Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) shares gained 54.15 percent to close at $9.48 on Friday.
  • Zosano Pharma Corp (NASDAQ: ZSAN) shares surged 39.38 percent to close at $7.61 on Friday as the company reported the Issuance of a new US patent covering M207 as an acute treatment for migraine.
  • Vectrus Inc (NYSE: VEC) shares gained 35.05 percent to close at $36.95 as the company posted better-than-expected quarterly results and issued a strong FY18 outlook.
  • Quality Care Properties, Inc. (NYSE: QCP) rose 29.05 percent to close at $16.26 after a report that the company plans to take over HCR ManorCare in a prepackaged Chapter 11 deal.
  • Veritiv Corporation (NYSE: VRTV) gained 25.53 percent to close at $35.40 following Q4 earnings.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) surged 25.2 percent to close at $6.36. T2 Biosystems is expected to release its Q4 operational results on Tuesday, March 6, 2018.
  • Intrexon Corporation (NYSE: XON) gained 24.73 percent to close at $16.09 following Q4 results.
  • American Public Education, Inc. (NASDAQ: APEI) shares jumped 24.34 percent to close at $35.25.
  • Nektar Therapeutics (NASDAQ: NKTR) shares rose 21.67 percent to close at $102.87 as the company posted a narrower-than-expected Q4 loss.
  • Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) shares gained 20.84 percent to close at $21.80 on Friday.
  • Southwestern Energy Company (NYSE: SWN) rose 20.49 percent to close at $4.47.
  • Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares gained 19.82 percent to close at $20.86.
  • 51job, Inc. (NASDAQ: JOBS) gained 18.42 percent to close at $76.39 on better-than-expected Q4 results.
  • Conatus Pharmaceuticals Inc (NASDAQ: CNAT) surged 17.92 percent to close at $6.12 on Friday. Oppenheimer initiated coverage on Conatus Pharmaceuticals with an Outperform rating.
  • Fate Therapeutics, Inc. (NASDAQ: FATE) gained 16.71 percent to close at $13.27. Fate Therapeutics is expected to release quarterly earnings on March 5, 2018.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) climbed 15.06 percent to close at $71.05 following Q4 results.
  • Ambarella Inc (NASDAQ: AMBA) rose 13.47 percent to close

continue reading

Interview with Chuck Akre, CEO, Akre Capital Management

By VW Staff. Originally published at ValueWalk.

Interview with Chuck Akre, CEO, Akre Capital Management

Get The Full Seth Klarman Series in PDF

Get the entire 10-part series on Seth Klarman in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Seth Klarman eBook

I went through college first 00:59 is a pre-med student and then as a 01:02 literature major and but nonetheless 01:06 when I graduated I have an interest in 01:10 and desire to to go out and create some 01:16 financial success and and talk to 01:22 actually this is probably not uncommon 01:24 but I went and talked to career 01:25 counselors in New York and and the idea 01:30 they suggested was go be a securities 01:32 analyst or broker and and I came back to 01:37 to Washington after that visit and 01:39 knocked on every brokerage door in 01:43 Washington in the summer of nineteen 01:46 sixty eight and a couple of them were 01:49 kind enough to entertain the idea and I 01:52 could start out as a as a rookie 01:56 stockbroker which is in fact what i did 01:58 in the summer of nineteen sixty eight 02:00 and having comment the business with no 02:06 financial background whatsoever it 02:10 didn’t soon cause me to 02:13 ask questions such as what makes a great 02:18 investor and more to the point what 02:21 makes a great investment and and invest 02:24 I was off on my journey to to make that 02:28 discovery and I worked at a brokerage 02:33 firm in Washington DC that when I joined 02:36 them was the single most important 02:39 brokerage in and banking firm in 02:41 Washington at that time having been the 02:44 capital markets raised capital raiser 02:47 for companies like Geico and Marietta 02:51 and all of the department stores and 02:53 drugstores and…
continue reading

China Confirms Further Economic Slowdown: Highlights From 2018 Government Work Report

Courtesy of ZeroHedge. View original post here.

In the latest confirmation that as part of its grand deleveraging campaign, China’s economy is set to slow further in the current year, Beijing has set a 2018 growth target of around 6.5%, omitting an intention to hit “a faster pace if possible”, as the world’s largest nation continues its push to ensure financial stability. While the target of 6.5% is the same as last year, Bloomberg notes that the statement excludes an objective for output growth to be “higher if possible in practice” as it did in 2017.

The omission from the GDP growth target of ‘higher if possible’ and the new lower budget deficit target suggest slower growth and a fiscal drag,” said Eurasia’s Callum Henderson. “This makes sense for China in the context of the new focus on financial de-risking, poverty alleviation and environment clean-up, but is less good news at the margin for those economies that have high export exposure to China.”

China’s newly downgraded growth target was released Monday ahead of Premier Li Keqiang’s report to the National People’s Congress gathering in Beijing.

While China’s GDP surpassed 2017’s target with 6.9% growth, the first acceleration since 2010, economists forecast a moderation to 6.5% this year amid the ongoing deleveraging drive and trade tensions with the Trump administration. To be sure President – or rather Emperor – Xi Jinping has made it clear he will accept slower growth in his push to curb pollution, poverty and debt risk at a time when the world’s second-largest economy is on a long-term growth slowdown. As a result, numerical GDP targets have been de-emphasized in favor of higher-quality expansion since last year, according to Bloomberg.

The government also signaled its intent to continue efforts to slow debt growth, and set the budget deficit target markedly lower, at 2.6% of GDP, down from 3% in the past two years; news of the proposed reduction in borrowing sent 10-year sovereign bonds futures higher last week after Bloomberg reported the plan to reduce the budget deficit target.

Commenting on the proposal, Bloomberg’s Asia economist Tom Orlik said that “Li’s plan for the year is consistent with a moderate slowdown in real growth,” noting that “there were signals of significantly reduced fiscal support for growth, and lower ambitions on capacity closures in the industrial sector.

Furthermore, authorities reiterated their prior…
continue reading

Visualizing How Money Is Spent By Different Income Groups

Courtesy of Zero Hedge

If you started making twice the amount of money that you do today, how would your spending habits change?

Consider if the tables were turned, and you instead were reduced to half of your current income. Where would you likely make cuts to spending?

As Visual Capitalist's Jeff Desjardins points out, the reality is that the money you have coming in has big implications on how expenses get prioritized – and so it’s interesting to see how people in different income brackets allocate what they have.

Courtesy of: Visual Capitalist

Visualizing Spending

Today’s series of graphics come to us from data visualization expert Nathan Yau at FlowingData, and they show how money is being spent by different income groups.

It uses data from the 2016 Consumer Expenditure Survey, an annual survey by the Bureau of Labor Statistics. Meanwhile, embedded words in the graphics come from Yau, as he makes observations on the data.

To Buy or Rent a House?

How do income groups differ in spending for housing?

Housing expenditures

Housing Expenses

How is money spent on utilities, furniture, and other household expenses?

Household expenditures

Food Expenses

Do income groups spend more eating at home, or eating out?

Food expenditures

Travel and Transportation

The cost of vehicles, gas, and other travel expenses.

Transportation expenditures

Health Expenditures

What about money spent on health insurance, services, or drugs?

Health expenditures

Pensions and Social Security

Lastly, the money going to retirement, pension, social security, and insurance plans.

Pensions expenditures

For more data analysis, as well as many other great visualizations on income, we highly recommend checking out FlowingData.

Sucker Traps & The Arithmetic Of Risk

Courtesy of Mike Shedlock, MishTalk

John Hussman has another excellent article out this week but it will be ignored. Mathematically, it must be ignored.

In the Arithmetic of Risk, Hussman posted the above chart. I added the anecdotes regarding where we are. Here are some pertinent snips.?

The collapse of major bubbles is often preceded by the collapse of smaller bubbles representing ‘fringe’ speculations. Those early wipeouts are canaries in the coalmine. Once investor preferences shift from speculation toward risk-aversion, extreme valuations should not be ignored, and can suddenly matter to their full extent.

At present, I view the market as a “broken parabola” – much the same as we observed for the Nikkei in 1990, the Nasdaq in 2000, or for those wishing a more recent example, Bitcoin since January.

Two features of the initial break from speculative bubbles are worth noting. First, the collapse of major bubbles is often preceded by the collapse of smaller bubbles representing “fringe” speculations. Those early wipeouts are canaries in the coalmine.

In July 2007, two Bear Stearns hedge funds heavily invested in sub-prime loans suddenly became nearly worthless. Yet that was nearly three months before the S&P 500 peaked in October, followed by a collapse that would take it down by more than 55%.

Observing the sudden collapses of fringe bubbles today, including inverse volatility funds and Bitcoin, my impression is that we’re actually seeing the early signs of risk-aversion and selectivity among investors. The speculation in Bitcoin, despite issues of scalability and breathtaking inefficiency, was striking enough. But the willingness of investors to short market volatility even at 9% was mathematically disturbing.

See, volatility is measured by the “standard deviation” of returns, which describes the spread of a bell curve, and can never become negative. Moreover, standard deviation is annualized by multiplying by the square root of time. An annual volatility of 9% implies a daily volatilty of about 0.6%, which is like saying that a 2% market decline should occur in fewer than 1 in 2000 trading sessions, when in fact they’ve historically occurred about 1 in 50. The spectacle of investors eagerly shorting a volatility index (VIX) of 9, in expectation that it would go lower, wasn’t just

continue reading

Eric Peters: Here’s The Real Point Behind Trump’s Trade War

Courtesy of ZeroHedge. View original post here.

Submitted and excerpted from the latest Weekly Notes by Eric Peters, CIO of One River Asset Management

The Point

“The import restrictions announced by the US President are likely to cause damage not only outside the US, but also to the US economy itself, including to its manufacturing and construction sectors, which are major users of aluminum and steel,” warned the IMF, their army of nerds in full sweat. Panic. Just 200k Americans work in steel, aluminum and iron. 5.5mm of our 154mm workers are employed by businesses that use steel. “How could the Americans make such an idiotic mistake?” howled the nerds. But of course, they entirely miss the point.

“If the EU wants to further increase their already massive tariffs and barriers on US companies doing business there, we will simply apply a Tax on their Cars which freely pour into the US. They make it impossible for our cars (and more) to sell there. Big trade imbalance!” tweeted Trump. The US currently imposes a 2.5% tariff on EU auto imports. The EU imposes a 10% tariff on US auto imports. Germany exports $25bln of autos to America annually. “US auto prices will rise,” warned the Washington Post. But of course, they entirely miss the point.

“Trade wars are good, easy to win,” tweeted Trump, knowing the statement would trigger every nerd with a college degree. Some worried about their jobs. But not terribly. Because their unemployment rate is just 2%, their labor force participation is 74%. They’re as well off as they’ve ever been. Particularly when set against those who never went to college, 5% of whom are unemployed, and 50% don’t even participate in the labor force. They’ve given up. These trade policies are for these forgotten people. To hell with the consequences. That’s the point.

FX Weekly Preview: A “Field Day” For The Algos This Week

Courtesy of ZeroHedge. View original post here.

Submitted by Shant Movsesian and Rajan Dhall MSTA at

FX Weekly Preview – A ‘field day’ for the algos this week

Back in the early 1990′s when I first started in the markets (interest rates and currencies), the level of volatility was a far cry from the pittance of price action we see today.  Through the mid 2000′s, the emergence of algorithmic and systems based trading accounts started to come to prominence, and in the aftermath of the 2007-2008 financial crises when stabilisation outside of the stock market euphoria took hold, ranges started to dwindle as liquidity and market making took shape in a different mold.  All well and good while data and event risk is perceived to be low, but then all hell breaks loose once realisation sets in and complacency is knocked.  

Well this week alone should offer a return to the times when intra day volatility allowed for price discovery is a little quicker than we normally see – and before everyone jumps down my throat, yes this is distorted beyond all sense of normality in equities – we are starting to see signs that macro themes are likely to become a little more mixed.  The cross rates are starting to break out a little more, pointing to differentiation away from just slamming the USD on every rally, though EUR dip buying is still heavily entrenched in the mindset.  

This weekend’s SPD confirmation of the vote to join Merkel’s CDU/CSU will somewhat predictably add a bid to the EUR tone first thing, assuming we get the hung parliament in Italy when the voting ends in Italy on Sunday night.  This seems to be the consensus view which analysts expect will maintain the status quo in the markets, but BTP spreads have been widening with German Bunds, so let’s wait and see the impact of the vote, whatever it is – all I can see is confusion at this point.  Any result can distract or exacerbate the underlying concerns over Italy’s banking systems (non performing loans etc), so we continue to see plenty of complacency over the component ingredients of Euro zone growth led/bolstered by Germany and its bloated current account surplus to boot.  

For EUR/USD, the obvious move is to head back to test 1.2400, then 1.2500, at
continue reading



#1 Performing Global Macro Hedge Fund Sees More Shorts Opportunities Ahead As China Bursts

By Jacob Wolinsky. Originally published at ValueWalk.

Crescat Global Macro Fund update to investors on 1/19/2019

Crescat Global Macro Fund and Crescat Long/Short fund delivered strong returns for both December and full year 2018 in a difficult market. Based on ...

more from ValueWalk

Zero Hedge

Johns Hopkins, Bristol-Myers Face $1 Billion Suit For Infecting Guatemalan Hookers With Syphilis 

Courtesy of ZeroHedge. View original post here.

A federal judge in Maryland said Johns Hopkins University, pharmaceutical company Bristol-Myers Squibb and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a top-secret program in the 1940s ran by the US government that injected hundreds of Guatemalans with syphilis, reported Reuters.

Several doctors from Hopkins an...

more from Tyler

Phil's Favorites

Divisive economics


Guest author David Brin — scientist, technology consultant, best-selling author and futurist — explores the records of Democrats and Republicans on the US economy in the following post. For David's latest posts, visit the CONTRARY BRIN blog. For his books and short stories, visit his web...

more from Ilene

Kimble Charting Solutions

Stock declines did not break 9-year support, says Joe Friday

Courtesy of Chris Kimble.

We often hear “Stocks take an escalator up and an elevator down!” No doubt stocks did experience a swift decline from the September highs to the Christmas eve lows. Looks like the “elevator” part of the phrase came true as 2018 was coming to an end.

The first part of the “stocks take an escalator up” seems to still be in play as well despite the swift decline of late.

Joe Friday Just The Facts Ma’am- All of these indices hit long-term rising support on Christmas Eve at each (1), where support held and rallies have followed.

If you find long-term perspectives helpf...

more from Kimble C.S.

Digital Currencies

Transparency and privacy: Empowering people through blockchain


Transparency and privacy: Empowering people through blockchain

Blockchain technologies can empower people by allowing them more control over their user data. Shutterstock

Courtesy of Ajay Kumar Shrestha, University of Saskatchewan

Blockchain has already proven its huge influence on the financial world with its first application in the form of cryptocurrencies such as Bitcoin. It might not be long before its impact is felt everywhere.

Blockchain is a secure chain of digital records that exist on multiple computers simultaneously so no record can be erased or falsified. The...

more from Bitcoin

Insider Scoop Explores Strategic Alternatives, Analyst Sees Possible Sale Price Around $30 Per Share

Courtesy of Benzinga.

Related 44 Biggest Movers From Yesterday 38 Stocks Moving In Wednesday's Mid-Day Session ... more from Insider

Chart School

Weekly Market Recap Jan 13, 2019

Courtesy of Blain.

In last week’s recap we asked:  “Has the Fed solved all the market’s problems in 1 speech?”

Thus far the market says yes!  As Guns n Roses preached – all we need is a little “patience”.  Four up days followed by a nominal down day Friday had the market following it’s normal pattern the past nearly 30 years – jumping whenever the Federal Reserve hints (or essentially says outright) it is here for the markets.   And in case you missed it the prior Friday, Chairman Powell came back out Thursday to reiterate the news – so…so… so… patient!

Fed Chairman Jerome Powell reinforced that message Thursday during a discussion at the Economic Club of Washington where he said that the central bank will be “fle...

more from Chart School

Members' Corner

Why Trump Can't Learn


Bill Eddy (lawyer, therapist, author) predicted Trump's chaotic presidency based on his high-conflict personality, which was evident years ago. This post, written in 2017, references a prescient article Bill wrote before Trump even became president, 5 Reasons Trump Can’t Learn. ~ Ilene 

Why Trump Can’t Learn

Donald Trump by Gage Skidmore (...

more from Our Members


Opening Pandora's Box: Gene editing and its consequences

Reminder: We are available to chat with Members, comments are found below each post.


Opening Pandora's Box: Gene editing and its consequences

Bacteriophage viruses infecting bacterial cells , Bacterial viruses. from

Courtesy of John Bergeron, McGill University

Today, the scientific community is aghast at the prospect of gene editing to create “designer” humans. Gene editing may be of greater consequence than climate change, or even the consequences of unleashing the energy of the atom.


more from Biotech

Mapping The Market

Trump: "I Won't Be Here" When It Blows Up

By Jean-Luc

Maybe we should simply try him for treason right now:

Trump on Coming Debt Crisis: ‘I Won’t Be Here’ When It Blows Up

The president thinks the balancing of the nation’s books is going to, ultimately, be a future president’s problem.

By Asawin Suebsaeng and Lachlan Markay, Daily Beast

The friction came to a head in early 2017 when senior officials offered Trump charts and graphics laying out the numbers and showing a “hockey stick” spike in the nationa...

more from M.T.M.


Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader


Free eBook - "My Top Strategies for 2017"



Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:


·       How 2017 Will Affect Oil, the US Dollar and the European Union


more from Promotions

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>